Sun Pharma agrees to acquire Organon in major India outbound deal worth billions. The deal marks one of the biggest cross-border acquisitions by an Indian firm.
Sun Pharma has agreed to acquire Organon, a New York-listed women's health-care company, in what is expected to be one of the largest India outbound deals in recent years.
What happened
Sun Pharma has agreed to acquire Organon, a New York-listed women's health-care company, in what is expected to be one of the largest India outbound deals in recent years.
Quick reaction
One tap helps tune what we surface next.
Reader discussion
Public commentsNo comments yet. Start the discussion around this signal.
Follow this signal
Get updates on this story
We will email you if this changes materially. No spam. Daily brief optional.
Map context
Open map near India
Keep the story in context with nearby live signals, countries, and category movement.
Related coverage
Briefings
More story pages
China is tightening approvals for overseas borrowings, forcing companies to scramble for cash with about $100 billion of bonds maturing this year.
China is tightening approvals for overseas borrowings, causing some companies to urgently seek cash as approximately $100 billion in bonds are set to mature this year.
Economists upgrade China's import growth forecast, expecting it to surpass export expansion for the first time since 2021.
Economists have significantly increased their projections for China's import growth, anticipating that it will exceed the pace of export expansion for the first time since 2021.
Emerging-market equities hit record high as AI optimism and Iran's Strait of Hormuz proposal boost sentiment.
Emerging-market equities reached a record high, supported by optimism over artificial intelligence and a report that Iran has proposed a new plan to reopen the Strait of Hormuz.
Budget airlines seek $2.5 billion in government aid, WSJ reports. Frontier and Avelo are among those seeking funds in exchange for warrants convertible to equity stakes.
Budget airlines, including Frontier and Avelo, are reportedly seeking $2.5 billion in government aid in exchange for warrants that could convert into equity stakes, the Wall Street Journal reports.
More live signals
Continue with the live feed.
The fastest nearby updates load from the public feed, not the enriched story endpoint.